Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog in Vitro and in Mice Bearing H69 Neuroendocrine Xenografts

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.115.164970
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Illuminating Somatostatin Analog Action at Neuroendocrine Tumor Receptors

Trends in Pharmacological Sciences
ToxicologyPharmacology
2013English

A Tumor-Selective Somatostatin Analog (TT-232) With Strong in Vitro and in Vivo Antitumor Activity.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Synthesis and Evaluation of a Fluorescent Ritterazine–Cephalostatin Hybrid

Organic Letters
BiochemistryOrganic ChemistryTheoretical ChemistryPhysical
2011English

Neuroendocrine Neoplasms and Somatostatin Receptor Subtypes Expression

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2016English

Somatostatin Analogue Treatment of Neuroendocrine Tumours.

Postgraduate Medical Journal
Medicine
1996English

Somatostatin Receptor Endoradiotherapy of Neuroendocrine Tumors: Experience in Hungarian Patients

Orvosi Hetilap
Medicine
2011English

Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Combination of 5-Fluorouracil With Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression and Radioligand Binding in Neuroendocrine Tumor Cells in Vitro

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

Evaluation in Vitro and in Rats Of161Tb-Dtpa-Octreotide, a Somatostatin Analogue With Potential for Intraoperative Scanning and Radiotherapy

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy